Recruit Strategic Partners has exited the identity management platform developer in a purchase by Ping Identity.
Month: October 2020
Winningtemp recruits Bonnier for series B
Bonnier Ventures co-led a $17.8m round for the employee engagement platform developer that will support international growth.
Taiyo takes up corporate venturing
The $10m investment fund formed by the electronic components manufacturer and its Taiyo America subsidiary will target developers of technologies and products related to its core business.
Merger and divestment natural responses
The so-called K economy this year, between primarily digital winners and a majority of laggards, is creating some resultant restructuring.
Twilio to add Segment in $3.2bn deal
GV is set to exit customer data management platform Segment in an all-share deal that more than doubles its valuation from 18 months ago.
Kronos Bio crushes IPO to raise $250m
GV-backed cancer drug developer Kronos Bio floated above its range in an upsized offering and saw its shares soar in price post-IPO.
Investors throw over $140m to 3DMed
Tigermed took part in a round that will support clinical progression of a 3D Medicines product pipeline that includes oncology candidate envafolimab.
Flash Express hurries to $200m series D
The e-commerce delivery service doubled its total funding in a PTT-led round that included TCP subsidiary Durbell and Krungsri Finnovate.
Galecto elects to target $100m in IPO
Merck Group, Bristol Myers-Squibb and Novo-backed cancer drug developer Galecto has filed to go public weeks after it last funding round.
Spruce Bio ups IPO to $90m
Novo remains the largest shareholder in the endocrine disorder drug developer, which went public in an upsized offering.
TigerConnect crafts $45m series D message
Relx and Telus-backed TigerConnect has now raised $149m in equity and debt financing for its healthcare messaging and collaboration platform.
Wei waves goodbye to Sabic Ventures
John Wei, a GCV Emerging Leaders award winner this year, is departing from Sabic Ventures after six years.
Evrythng tracks down $10m
You & Mr Jones put up a share of the funding as the consumer data technology provider took its overall funding to $60m.
Analysis: 10x Genomics acquires ReadCoor for $350m
Eli Lilly is to exit the genetic sequencing system provider Readcoor in a cash-and-share acquisition by 10x Genomics. This is one of the relatively few exits we have seen in this space over the past decade.